Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised controlled, two-arm, assessor-blinded trial
The ELAN trial aims to estimate the net benefit of early versus late (current standard practice) initiation of direct oral anticoagulants (DOACs) in patients with acute ischaemic stroke related to atrial fibrillation.
Lead Site: University Hospital Bern, Switzerland
Principle Investigator: Dr Ben Grimshaw
End date: 01/02/2021
The following studies are currently paused due to COVID-19:
The Hemianopia Activity Based InTervention (HABIT): refining and operationalising a rehabilitation intervention for visual field loss after stroke.
Led by Dr Philip Clatworthy, this study aims to produce a treatment for loss of vision after stroke in adults that can be used in NHS services from early hospital-based rehabilitation to rehabilitation and care at home.
Host Site: North Bristol NHS Trust
Chief Investigator: Dr Phil Clatworthy
Trial Manager: Hannah Sheridan
End date: 12/11/2021
ICONS II is a randomised controlled trial to compare the effectiveness and cost-effectiveness of a systematic voiding programme with usual care in reducing the severity of urinary incontinence in patients with stroke.
Lead Site: University of Central Lancashire
Principle Investigators: Dr Phil Clatworthy & Kerry Smith
End date: 31/05/2020